封面
市场调查报告书
商品编码
1825467

2025年MRI显影剂全球市场报告

MRI Contrast Media Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年MRI显影剂市场规模将强劲成长,到2029年将达到20.6亿美元,复合年增长率为5.5%。预测期内的成长归因于癌症患者数量的增加、慢性病盛行率的上升、研发投入和活动的增加、医疗保健支出的增加以及MRI应用的不断扩展。预测期内的主要趋势包括合作的加强、技术进步、产品创新、更安全、更有效的显影剂的开发,以及製药和生物技术公司的产品创新。

未来五年5.5%的预测成长率,较我们先前对该市场的预测略有下降0.5%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将对放射科带来压力,导致来自挪威和比利时的钆基显影剂和注射剂的成本上升,从而减慢影像处理速度,并增加医院影像中心的成本。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响,其影响也将更加广泛。

预计癌症患者数量的增加将推动 MRI显影剂市场的成长。癌症患者数量的增加归因于许多因素,包括人口变化、生活方式选择、环境影响、遗传易感性和医疗保健进步。 MRI 检查利用含钆基化合物的显影剂,透过改变组织的磁性来增强可视化,有助于肿瘤的检测、大小测定和表征,以及评估肿瘤对周围组织的侵袭。例如,根据世界卫生组织 (WHO) 于 2024 年 2 月发布的报告,预计 2022 年全球新增癌症病例数将激增至 2,000 万,导致 970 万人死亡。预测显示,到 2050 年癌症病例数将大幅增加,达到 3,500 万以上,比 2022 年估计的 2,000 万例增加 77%。因此,癌症发生率的上升正在推动 MRI显影剂市场的扩张。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通膨、地缘政治、贸易战和关税,以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球 MRI显影剂:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 最终用途产业分析
  • 全球 MRI显影剂市场:成长率分析
  • 全球 MRI显影剂市场表现:规模与成长,2019-2024 年
  • 全球 MRI显影剂市场预测:规模与成长,2024-2029 年,2034 年
  • 全球 MRI显影剂:总目标市场(TAM)

第六章 市场细分

  • 全球 MRI显影剂市场:按产品、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 细胞外造影显影剂
  • 血池特工
  • 肝胆药物
  • 全球 MRI显影剂市场:按应用、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 神经系统疾病
  • 肌肉骨骼疾病
  • 心血管疾病
  • 癌症检测
  • 其他用途
  • 全球 MRI显影剂市场:按最终用户、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断和影像中心
  • 研究机构
  • 其他最终用户
  • 全球 MRI显影剂市场:按细胞显影剂类型细分、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 钆显影剂(GBCA)
  • 钆以外的显影剂
  • 全球 MRI显影剂市场:依血池造影剂类型细分、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 高分子药物
  • 基于奈米颗粒的药物
  • 全球 MRI显影剂市场:肝胆造影剂细分(按类型)、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 肝细胞特异性药物
  • 胆汁特异性药物

第七章 区域和国家分析

  • 全球 MRI显影剂市场:区域表现及预测(2019-2024 年、2024-2029 年及 2034 年)
  • 全球 MRI显影剂市场:依国家/地区、绩效及预测,2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第18章:法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章:竞争格局与公司概况

  • MRI显影剂市场:竞争格局
  • MRI显影剂市场:公司简介
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • JB Chemicals and Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • Jiangsu Hengrui Pharmaceutical Co. Ltd.
  • Bracco SpA
  • Miltenyi Biotec BV & Co. KG
  • Lantheus Medical Imaging Inc.
  • Guerbet LLC
  • Curium Pharma
  • Spago Nanomedical AB
  • AMAG Pharmaceuticals Inc.
  • Nanopet Pharma GmbH
  • Trivitron Healthcare
  • Beijing Beilu Pharmaceuticals Company Limited
  • Unijules Life Sciences Ltd.
  • Taejoon Pharm Co. Ltd.
  • Mediso USA LLC
  • Nano Therapeutics Pvt. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章:高潜力市场国家、细分市场与策略

  • 2029 年 MRI显影剂市场:提供新机会的国家
  • 2029 年 MRI显影剂市场:细分市场将带来新机会
  • MRI显影剂市场2029年:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r28561u

MRI contrast media refers to substances utilized in magnetic resonance imaging (MRI) to heighten the visibility of internal body structures. These contrast agents function by modifying the magnetic properties of tissues, thereby enhancing the contrast in resultant images.

The primary MRI contrast media products include extracellular contrast agents, blood-pool agents, and hepatobiliary agents. Extracellular contrast agents are employed in MRI to augment the visibility of internal body structures. They find application in diagnosing various conditions such as neurological disorders, musculoskeletal disorders, cardiovascular disorders, cancer detection, and more. These products are utilized by a range of end-users including hospitals, diagnostic and imaging centers, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The MRI contrast media market research report is one of a series of new reports from The Business Research Company that provides MRI contrast media market statistics, including MRI contrast media industry global market size, regional shares, competitors with an MRI contrast media market share, detailed MRI contrast media market segments, market trends, and opportunities, and any further data you may need to thrive in the MRI contrast media industry. This MRI contrast media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mri contrast media market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising demand for early diagnosis, increasing demand for diagnostic accuracy and patient outcomes, increased public awareness, development of combination imaging modalities, identification of novel use cases for contrast agents.

The mri contrast media market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in cancer cases, growing prevalence of chronic diseases, increasing research and development investment and activities, increasing healthcare expenditure, expanding applications of MRI. Major trends in the forecast period include advancement with collaborative research, technological advancements, product innovation, development of safer and more effective contrast agents, product innovations by pharmaceutical and biotechnology companies.

The forecast of 5.5% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to strain radiology departments by increasing the cost of gadolinium-based contrast agents and injectable formulations sourced from Norway and Belgium, thereby delaying diagnostic imaging and elevating hospital imaging center costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in cancer cases is expected to drive growth within the MRI contrast media market. This rise in cancer cases is attributed to a multitude of factors, including demographic shifts, lifestyle choices, environmental influences, genetic predispositions, and advancements in healthcare practices. MRI scans utilize contrast agents containing gadolinium-based compounds to enhance visualization by modifying tissue magnetic properties, aiding in the detection, sizing, and characterization of tumors, as well as evaluating their invasion into surrounding tissues. For instance, a report published by the World Health Organization (WHO) in February 2024 revealed that the global estimated number of new cancer cases surged to 20 million in 2022, resulting in 9.7 million deaths. Projections indicate a substantial increase in cancer cases by 2050, with an anticipated 77% rise to over 35 million new cases, compared to the estimated 20 million cases in 2022. Hence, the mounting incidence of cancer serves as a driving force behind the expansion of the MRI contrast media market.

Key players in the MRI contrast media market are strategically focused on developing and distributing advanced products, such as macrocyclic gadolinium-based contrast agents (GBCA), to augment the diagnostic capabilities and safety profile of MRI imaging procedures. Macrocyclic gadolinium-based contrast agents (GBCA) represent a category of contrast agents utilized in medical imaging, particularly in magnetic resonance imaging (MRI). For instance, in February 2023, Guerbet, a France-based provider of MRI contrast media, unveiled the Elucirem (gadopiclenol) injection. Distinguished by its highly stable macrocyclic gadolinium-based contrast agent (GBCA), Elucirem (gadopiclenol) injection boasts the highest relaxivity in its class for MRI. This innovative formulation of gadopiclenol demonstrates exceptional efficacy in detecting and visualizing lesions with abnormal vascularity across various regions of the central nervous system and the body.

In March 2023, Bracco Imaging S.p.A., an Italy-based healthcare company, concluded the acquisition of the remaining 49% stake in Bracco-Eisai Co. Ltd. for an undisclosed sum. This strategic move is aimed at facilitating swift and adaptable responses to the evolving healthcare industry landscape, with a focus on achieving sustainable contributions to patient care through product utilization. Bracco-Eisai Co. Ltd., based in Japan, is recognized for its provision of MRI contrast media, contributing to Bracco Imaging S.p.A.'s comprehensive portfolio of healthcare solutions.

Major companies operating in the MRI contrast media market are Bayer AG, GE Healthcare Technologies Inc., Fresenius Kabi AG, Fujifilm Holdings Corporation, JB Chemicals and Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd., Bracco S.p.A., Miltenyi Biotec B.V. & Co. KG, Lantheus Medical Imaging Inc., Guerbet LLC, Curium Pharma, Spago Nanomedical AB, AMAG Pharmaceuticals Inc., Nanopet Pharma GmbH, Trivitron Healthcare, Beijing Beilu Pharmaceuticals Company Limited, Unijules Life Sciences Ltd., Taejoon Pharm Co. Ltd., Mediso USA LLC, Nano Therapeutics Pvt. Ltd., Livealth Biopharma Pvt Ltd., BioPAL Inc., Vitalquan LLC, Shubhra Biotech Pvt Ltd., Rege Imaging & Cine Films Private Limited, Polarean Inc.

North America was the largest region in the MRI contrast media market in 2024. The regions covered in the mri contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mri contrast media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The MRI contrast media market consists of sales of gadopentetate dimeglumine (Gd-DTPA), gadodiamide, diatrizoate, and gadoversetamide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

MRI Contrast Media Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mri contrast media market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mri contrast media ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mri contrast media market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Extracellular Contrast Agents; Blood-Pool Agent; Hepatobiliary Agents
  • 2) By Application: Neurological Disorders; Musculoskeletal Disorders; Cardiovascular Disorders; Cancer Detection; Other Applications
  • 3) By End-User: Hospitals; Diagnostic And Imaging Centers; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Extracellular Contrast Agents: Gadolinium-Based Contrast Agents (GBCA); Non-Gadolinium-Based Contrast Agents
  • 2) By Blood-Pool Agent: Macromolecular Agents; Nanoparticle-Based Agents
  • 3) By Hepatobiliary Agents: Hepatocyte-Specific Agents; Biliary-Specific Agents
  • Companies Mentioned: Bayer AG; GE Healthcare Technologies Inc.; Fresenius Kabi AG; Fujifilm Holdings Corporation; JB Chemicals and Pharmaceuticals Ltd.; Jiangsu Hengrui Pharmaceutical Co. Ltd.; Bracco S.p.A.; Miltenyi Biotec B.V. & Co. KG; Lantheus Medical Imaging Inc.; Guerbet LLC; Curium Pharma; Spago Nanomedical AB; AMAG Pharmaceuticals Inc.; Nanopet Pharma GmbH; Trivitron Healthcare; Beijing Beilu Pharmaceuticals Company Limited; Unijules Life Sciences Ltd.; Taejoon Pharm Co. Ltd.; Mediso USA LLC; Nano Therapeutics Pvt. Ltd.; Livealth Biopharma Pvt Ltd.; BioPAL Inc.; Vitalquan LLC; Shubhra Biotech Pvt Ltd; Rege Imaging & Cine Films Private Limited; Polarean Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. MRI Contrast Media Market Characteristics

3. MRI Contrast Media Market Trends And Strategies

4. MRI Contrast Media Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global MRI Contrast Media Growth Analysis And Strategic Analysis Framework

  • 5.1. Global MRI Contrast Media PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global MRI Contrast Media Market Growth Rate Analysis
  • 5.4. Global MRI Contrast Media Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global MRI Contrast Media Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global MRI Contrast Media Total Addressable Market (TAM)

6. MRI Contrast Media Market Segmentation

  • 6.1. Global MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Extracellular Contrast Agents
  • Blood-Pool Agent
  • Hepatobiliary Agents
  • 6.2. Global MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Cardiovascular Disorders
  • Cancer Detection
  • Other Applications
  • 6.3. Global MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic And Imaging Centers
  • Research Institutes
  • Other End Users
  • 6.4. Global MRI Contrast Media Market, Sub-Segmentation Of Extracellular Contrast Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gadolinium-Based Contrast Agents (GBCA)
  • Non-Gadolinium-Based Contrast Agents
  • 6.5. Global MRI Contrast Media Market, Sub-Segmentation Of Blood-Pool Agent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Macromolecular Agents
  • Nanoparticle-Based Agents
  • 6.6. Global MRI Contrast Media Market, Sub-Segmentation Of Hepatobiliary Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatocyte-Specific Agents
  • Biliary-Specific Agents

7. MRI Contrast Media Market Regional And Country Analysis

  • 7.1. Global MRI Contrast Media Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global MRI Contrast Media Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific MRI Contrast Media Market

  • 8.1. Asia-Pacific MRI Contrast Media Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China MRI Contrast Media Market

  • 9.1. China MRI Contrast Media Market Overview
  • 9.2. China MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India MRI Contrast Media Market

  • 10.1. India MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan MRI Contrast Media Market

  • 11.1. Japan MRI Contrast Media Market Overview
  • 11.2. Japan MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia MRI Contrast Media Market

  • 12.1. Australia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia MRI Contrast Media Market

  • 13.1. Indonesia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea MRI Contrast Media Market

  • 14.1. South Korea MRI Contrast Media Market Overview
  • 14.2. South Korea MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe MRI Contrast Media Market

  • 15.1. Western Europe MRI Contrast Media Market Overview
  • 15.2. Western Europe MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK MRI Contrast Media Market

  • 16.1. UK MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany MRI Contrast Media Market

  • 17.1. Germany MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France MRI Contrast Media Market

  • 18.1. France MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy MRI Contrast Media Market

  • 19.1. Italy MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain MRI Contrast Media Market

  • 20.1. Spain MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe MRI Contrast Media Market

  • 21.1. Eastern Europe MRI Contrast Media Market Overview
  • 21.2. Eastern Europe MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia MRI Contrast Media Market

  • 22.1. Russia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America MRI Contrast Media Market

  • 23.1. North America MRI Contrast Media Market Overview
  • 23.2. North America MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA MRI Contrast Media Market

  • 24.1. USA MRI Contrast Media Market Overview
  • 24.2. USA MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada MRI Contrast Media Market

  • 25.1. Canada MRI Contrast Media Market Overview
  • 25.2. Canada MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America MRI Contrast Media Market

  • 26.1. South America MRI Contrast Media Market Overview
  • 26.2. South America MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil MRI Contrast Media Market

  • 27.1. Brazil MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East MRI Contrast Media Market

  • 28.1. Middle East MRI Contrast Media Market Overview
  • 28.2. Middle East MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa MRI Contrast Media Market

  • 29.1. Africa MRI Contrast Media Market Overview
  • 29.2. Africa MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. MRI Contrast Media Market Competitive Landscape And Company Profiles

  • 30.1. MRI Contrast Media Market Competitive Landscape
  • 30.2. MRI Contrast Media Market Company Profiles
    • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. JB Chemicals and Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. MRI Contrast Media Market Other Major And Innovative Companies

  • 31.1. Jiangsu Hengrui Pharmaceutical Co. Ltd.
  • 31.2. Bracco S.p.A.
  • 31.3. Miltenyi Biotec B.V. & Co. KG
  • 31.4. Lantheus Medical Imaging Inc.
  • 31.5. Guerbet LLC
  • 31.6. Curium Pharma
  • 31.7. Spago Nanomedical AB
  • 31.8. AMAG Pharmaceuticals Inc.
  • 31.9. Nanopet Pharma GmbH
  • 31.10. Trivitron Healthcare
  • 31.11. Beijing Beilu Pharmaceuticals Company Limited
  • 31.12. Unijules Life Sciences Ltd.
  • 31.13. Taejoon Pharm Co. Ltd.
  • 31.14. Mediso USA LLC
  • 31.15. Nano Therapeutics Pvt. Ltd.

32. Global MRI Contrast Media Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The MRI Contrast Media Market

34. Recent Developments In The MRI Contrast Media Market

35. MRI Contrast Media Market High Potential Countries, Segments and Strategies

  • 35.1 MRI Contrast Media Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 MRI Contrast Media Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 MRI Contrast Media Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer